Effect of combined treatment with insulin, metformin, and gliclazide on the expression and activity of Akt, mTOR, and p70S6K protein kinases in lymphocytes of diabetic patients
The expression of the main effector protein kinase Akt of the PI3K signaling pathway and the activities of mTOR
 and p70S6K protein kinases in lymphocytes of patients with diabetes mellitus are determined at the combination
 treatment with insulin and hypoglycemic drugs. It is shown...
Saved in:
| Published in: | Доповіді НАН України |
|---|---|
| Date: | 2018 |
| Main Authors: | Sokolova, L.K., Pushkarev, V.M., Belchina, Yu.B., Pushkarev, V.V., Vatseba, T.S., Tronko, M.D. |
| Format: | Article |
| Language: | English |
| Published: |
Видавничий дім "Академперіодика" НАН України
2018
|
| Subjects: | |
| Online Access: | https://nasplib.isofts.kiev.ua/handle/123456789/143441 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Journal Title: | Digital Library of Periodicals of National Academy of Sciences of Ukraine |
| Cite this: | Effect of combined treatment with insulin, metformin, and gliclazide on the expression and activity of Akt, mTOR, and p70S6K protein kinases in lymphocytes of diabetic patients / L.K. Sokolova, V.M. Pushkarev, Yu.B. Belchina, V.V. Pushkarev, T.S. Vatseba, M.D. Tronko // Доповіді Національної академії наук України. — 2018. — № 8. — С. 105-109. — Бібліогр.: 14 назв. — англ. |
Institution
Digital Library of Periodicals of National Academy of Sciences of UkraineSimilar Items
Effect of combined treatment with insulin, metformin, and gliclazide on the expression and activity of Akt, mTOR, and p70S6K protein kinases in lymphocytes of diabetic patients
by: L. K. Sokolova, et al.
Published: (2018)
by: L. K. Sokolova, et al.
Published: (2018)
Effect of combined treatment with insulin and metformin on 5′AMPactivated protein kinase activity in lymphocytes of diabetic patients
by: Sokolova, L.K., et al.
Published: (2018)
by: Sokolova, L.K., et al.
Published: (2018)
Effect of combined trea tment with insulin and metformin on 5'AMPactivated protein kinase activity in lymphocytes of diabetic patients
by: L. K. Sokolova, et al.
Published: (2018)
by: L. K. Sokolova, et al.
Published: (2018)
Activation of the PI3K/Akt/mTOR/p70S6K1 signaling cascade in peripheral blood mononuclear cells in patients with type 2 diabetes
by: T. S. Vatseba, et al.
Published: (2020)
by: T. S. Vatseba, et al.
Published: (2020)
The activity of adenosine monophosphate-activated protein kinase in lymphocytes under the action of hypoglycemic drugs
by: L. K. Sokolova, et al.
Published: (2017)
by: L. K. Sokolova, et al.
Published: (2017)
Protein kinase Akt activity in human thyroid tumors
by: B. B. Guda, et al.
Published: (2016)
by: B. B. Guda, et al.
Published: (2016)
Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulin receptor substrate-1 amount in the blood plasma of patients
by: Tronko, M.D., et al.
Published: (2021)
by: Tronko, M.D., et al.
Published: (2021)
Phospho-mTOR (Ser2481) colocalizes with condensed chromosomes during metaphase
by: V. R. Kosach, et al.
Published: (2016)
by: V. R. Kosach, et al.
Published: (2016)
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: Tronko, M.D., et al.
Published: (2021)
by: Tronko, M.D., et al.
Published: (2021)
NT-proBNP blood levels in patients with type 2 diabetes mellitus with anemia and after the dapagliflozin treatment
by: Sokolova, L.K., et al.
Published: (2018)
by: Sokolova, L.K., et al.
Published: (2018)
Characteristic of mTOR signaling and its involvement in the regulation of cell movements through remodeling the cytoskeleton architecture
by: V. R. Kosach, et al.
Published: (2015)
by: V. R. Kosach, et al.
Published: (2015)
Characteristic of mTOR signaling and its involvement in the regulation of cell movements through remodeling the cytoskeleton architecture
by: Kosach, V.R., et al.
Published: (2015)
by: Kosach, V.R., et al.
Published: (2015)
Apolipoprotein B and oxLDL levels in plasma of patients with diabetes, cardiovascular disease, and COVID-19
by: Tronko, M.D., et al.
Published: (2021)
by: Tronko, M.D., et al.
Published: (2021)
PI3K/mTOR/S6K signaling pathway – new players and new functional links
by: Filonenko, V.V.
Published: (2013)
by: Filonenko, V.V.
Published: (2013)
PI3K/mTOR/S6K signaling pathway – new players and new functional links
by: V. V. Filonenko
Published: (2013)
by: V. V. Filonenko
Published: (2013)
PI3K/mTOR-dependent signaling pathway as a possible regulator of processing body assembly
by: Gudkova, D.O., et al.
Published: (2011)
by: Gudkova, D.O., et al.
Published: (2011)
The expression of Akt kinase in the heart ventricles under hypoxic preconditioning and myocardial remodeling
by: A. G. Portnichenko, et al.
Published: (2013)
by: A. G. Portnichenko, et al.
Published: (2013)
The expression and the activation of protein kinase Akt/PKB in normal tissues, benign and highly differentiated malignant human thyroid tumors
by: B. B. Huda, et al.
Published: (2016)
by: B. B. Huda, et al.
Published: (2016)
Apolipoprotein A1 level in plasma of patients with diabetes and diabetic patients with COVID-19 as a possible marker of disease
by: M. D. Tronko, et al.
Published: (2021)
by: M. D. Tronko, et al.
Published: (2021)
Activation of protein kinase p70S6K1 in peripheral blood mononuclear cells of patients with cancer and diabetes
by: T. S. Vatseba, et al.
Published: (2019)
by: T. S. Vatseba, et al.
Published: (2019)
Effects of COVID-19, diabetes mellitus, and cardiovascular diseases on insulinre ceptor substrate-1 amount in the blood plasma of patients
by: M. D. Tronko, et al.
Published: (2021)
by: M. D. Tronko, et al.
Published: (2021)
Metformin as a modifier of the oxidative status of peripheral blood and the viability of human lymphocytes under the influence of ionizing radiation
by: O. A. Hlavin, et al.
Published: (2020)
by: O. A. Hlavin, et al.
Published: (2020)
Effects of COVID-19 and diabetes mellitus on AMPKα1 and IRS-1 amount in the blood plasma of patients
by: M. D. Tronko, et al.
Published: (2022)
by: M. D. Tronko, et al.
Published: (2022)
NT-proBNP blood levels in patients with type 2 diabetes mellitus with anemia and after the dapagliflozin treatment
by: L. K. Sokolova, et al.
Published: (2018)
by: L. K. Sokolova, et al.
Published: (2018)
Bradykinin content in the blood of patients with COVID-19 and diabetes mellitus
by: M. D. Tronko, et al.
Published: (2024)
by: M. D. Tronko, et al.
Published: (2024)
Absolute insulin insufficiency in different variants of diabetes mellitus
by: T. M. Tikhonova, et al.
Published: (2018)
by: T. M. Tikhonova, et al.
Published: (2018)
Untitled
by: M. D. Tronko, et al.
Published: (2021)
by: M. D. Tronko, et al.
Published: (2021)
The role of PPARs and his isoforms in the metabolic disorder related to insulin resistance and diabetes
by: N. A. Kravchenko, et al.
Published: (2011)
by: N. A. Kravchenko, et al.
Published: (2011)
Metformin plus PIAF combination chemotherapy for hepatocellular carcinoma
by: Petrushev, B., et al.
Published: (2012)
by: Petrushev, B., et al.
Published: (2012)
Bakhmut, tor and maiaky cossacks in the 18-th century
by: I. A. Kornatskyi
Published: (2012)
by: I. A. Kornatskyi
Published: (2012)
Metformin therapy for patients with metabolic syndrom associated with chronic pancreatitis
by: O. Bondarenko, et al.
Published: (2017)
by: O. Bondarenko, et al.
Published: (2017)
Biochemical effects of combined action of γ-irradiation and paclitaxel on anaplastic thyroid cancer cells
by: V. M. Pushkarev, et al.
Published: (2013)
by: V. M. Pushkarev, et al.
Published: (2013)
Time-dependent cytotoxicity of dichloroacetate and metformin against Lewis lung carcinoma
by: Kolesnik, D.L., et al.
Published: (2023)
by: Kolesnik, D.L., et al.
Published: (2023)
Isolation and characterization of insulin receptor of plasma membranes of rat liver cells at type 2 diabetes model
by: T. I. Halenova, et al.
Published: (2014)
by: T. I. Halenova, et al.
Published: (2014)
Insulin resistance indexes in patients with ischemic cardiac disease without diabetes mellitus during statine treatment
by: O. Bondarenko, et al.
Published: (2016)
by: O. Bondarenko, et al.
Published: (2016)
Insulin determination in pancreas of guinea pigs with metabolic syndrome
by: V. V. Rushchak, et al.
Published: (2014)
by: V. V. Rushchak, et al.
Published: (2014)
Insulin like growth factor-1: neurophysiological aspects
by: Ju. Garmatina
Published: (2015)
by: Ju. Garmatina
Published: (2015)
Composition material on the basis of a carbohydrate fiber matrix with immobilized insulin for the development of a new me dicine form: transdermal insulin plate
by: V. P. Serhieiev, et al.
Published: (2019)
by: V. P. Serhieiev, et al.
Published: (2019)
CD150-mediated Akt signalling pathway in normal and malignant B cells
by: Yurchenko, M., et al.
Published: (2011)
by: Yurchenko, M., et al.
Published: (2011)
Effects of Paclitaxel and combination of the drug with radiation therapy in an in vivo model of anaplastic thyroid carcinoma
by: Pushkarev, V.M., et al.
Published: (2011)
by: Pushkarev, V.M., et al.
Published: (2011)
Similar Items
-
Effect of combined treatment with insulin, metformin, and gliclazide on the expression and activity of Akt, mTOR, and p70S6K protein kinases in lymphocytes of diabetic patients
by: L. K. Sokolova, et al.
Published: (2018) -
Effect of combined treatment with insulin and metformin on 5′AMPactivated protein kinase activity in lymphocytes of diabetic patients
by: Sokolova, L.K., et al.
Published: (2018) -
Effect of combined trea tment with insulin and metformin on 5'AMPactivated protein kinase activity in lymphocytes of diabetic patients
by: L. K. Sokolova, et al.
Published: (2018) -
Activation of the PI3K/Akt/mTOR/p70S6K1 signaling cascade in peripheral blood mononuclear cells in patients with type 2 diabetes
by: T. S. Vatseba, et al.
Published: (2020) -
The activity of adenosine monophosphate-activated protein kinase in lymphocytes under the action of hypoglycemic drugs
by: L. K. Sokolova, et al.
Published: (2017)